Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Drug Repositioning Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Repositioning Market Perspective (2016-2027)
2.2 Drug Repositioning Growth Trends by Regions
2.2.1 Drug Repositioning Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repositioning Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repositioning Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repositioning Industry Dynamic
2.3.1 Drug Repositioning Market Trends
2.3.2 Drug Repositioning Market Drivers
2.3.3 Drug Repositioning Market Challenges
2.3.4 Drug Repositioning Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Repositioning Players by Revenue
3.1.1 Global Top Drug Repositioning Players by Revenue (2016-2021)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repositioning Revenue
3.4 Global Drug Repositioning Market Concentration Ratio
3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2020
3.5 Drug Repositioning Key Players Head office and Area Served
3.6 Key Players Drug Repositioning Product Solution and Service
3.7 Date of Enter into Drug Repositioning Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Repositioning Breakdown Data by Type
4.1 Global Drug Repositioning Historic Market Size by Type (2016-2021)
4.2 Global Drug Repositioning Forecasted Market Size by Type (2022-2027)

5 Drug Repositioning Breakdown Data by Application
5.1 Global Drug Repositioning Historic Market Size by Application (2016-2021)
5.2 Global Drug Repositioning Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Repositioning Market Size (2016-2027)
6.2 North America Drug Repositioning Market Size by Type
6.2.1 North America Drug Repositioning Market Size by Type (2016-2021)
6.2.2 North America Drug Repositioning Market Size by Type (2022-2027)
6.2.3 North America Drug Repositioning Market Size by Type (2016-2027)
6.3 North America Drug Repositioning Market Size by Application
6.3.1 North America Drug Repositioning Market Size by Application (2016-2021)
6.3.2 North America Drug Repositioning Market Size by Application (2022-2027)
6.3.3 North America Drug Repositioning Market Size by Application (2016-2027)
6.4 North America Drug Repositioning Market Size by Country
6.4.1 North America Drug Repositioning Market Size by Country (2016-2021)
6.4.2 North America Drug Repositioning Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drug Repositioning Market Size (2016-2027)
7.2 Europe Drug Repositioning Market Size by Type
7.2.1 Europe Drug Repositioning Market Size by Type (2016-2021)
7.2.2 Europe Drug Repositioning Market Size by Type (2022-2027)
7.2.3 Europe Drug Repositioning Market Size by Type (2016-2027)
7.3 Europe Drug Repositioning Market Size by Application
7.3.1 Europe Drug Repositioning Market Size by Application (2016-2021)
7.3.2 Europe Drug Repositioning Market Size by Application (2022-2027)
7.3.3 Europe Drug Repositioning Market Size by Application (2016-2027)
7.4 Europe Drug Repositioning Market Size by Country
7.4.1 Europe Drug Repositioning Market Size by Country (2016-2021)
7.4.2 Europe Drug Repositioning Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Repositioning Market Size (2016-2027)
8.2 Asia-Pacific Drug Repositioning Market Size by Type
8.2.1 Asia-Pacific Drug Repositioning Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repositioning Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repositioning Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repositioning Market Size by Application
8.3.1 Asia-Pacific Drug Repositioning Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repositioning Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repositioning Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repositioning Market Size by Region
8.4.1 Asia-Pacific Drug Repositioning Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repositioning Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Repositioning Market Size (2016-2027)
9.2 Latin America Drug Repositioning Market Size by Type
9.2.1 Latin America Drug Repositioning Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repositioning Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repositioning Market Size by Type (2016-2027)
9.3 Latin America Drug Repositioning Market Size by Application
9.3.1 Latin America Drug Repositioning Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repositioning Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repositioning Market Size by Application (2016-2027)
9.4 Latin America Drug Repositioning Market Size by Country
9.4.1 Latin America Drug Repositioning Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repositioning Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Repositioning Market Size (2016-2027)
10.2 Middle East & Africa Drug Repositioning Market Size by Type
10.2.1 Middle East & Africa Drug Repositioning Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repositioning Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repositioning Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repositioning Market Size by Application
10.3.1 Middle East & Africa Drug Repositioning Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repositioning Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repositioning Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repositioning Market Size by Country
10.4.1 Middle East & Africa Drug Repositioning Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repositioning Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Drug Repositioning Introduction
11.1.4 Teva Revenue in Drug Repositioning Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Repositioning Introduction
11.2.4 Novartis Revenue in Drug Repositioning Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Drug Repositioning Introduction
11.3.4 Mylan Revenue in Drug Repositioning Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Drug Repositioning Introduction
11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repositioning Introduction
11.5.4 Pfizer Revenue in Drug Repositioning Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Drug Repositioning Introduction
11.6.4 Bausch Health Revenue in Drug Repositioning Business (2016-2021)
11.6.5 Bausch Health Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Drug Repositioning Introduction
11.7.4 GSK Revenue in Drug Repositioning Business (2016-2021)
11.7.5 GSK Recent Development
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Drug Repositioning Introduction
11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2016-2021)
11.8.5 ChemRar Group Recent Development
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Drug Repositioning Introduction
11.9.4 Glenmark Revenue in Drug Repositioning Business (2016-2021)
11.9.5 Glenmark Recent Development
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Drug Repositioning Introduction
11.10.4 Fujifilm Revenue in Drug Repositioning Business (2016-2021)
11.10.5 Fujifilm Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Drug Repositioning Introduction
11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2016-2021)
11.11.5 Dr. Reddy Recent Development
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Drug Repositioning Introduction
11.12.4 R-Pharma Revenue in Drug Repositioning Business (2016-2021)
11.12.5 R-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Clinical Trial Failed Drugs
Table 4. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Drug Repositioning Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Drug Repositioning Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Drug Repositioning Market Share by Regions (2016-2021)
Table 8. Global Drug Repositioning Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Drug Repositioning Market Share by Regions (2022-2027)
Table 10. Drug Repositioning Market Trends
Table 11. Drug Repositioning Market Drivers
Table 12. Drug Repositioning Market Challenges
Table 13. Drug Repositioning Market Restraints
Table 14. Global Drug Repositioning Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Drug Repositioning Market Share by Players (2016-2021)
Table 16. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repositioning as of 2020)
Table 17. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Repositioning Product Solution and Service
Table 21. Date of Enter into Drug Repositioning Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Drug Repositioning Revenue Market Share by Type (2016-2021)
Table 25. Global Drug Repositioning Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Drug Repositioning Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Drug Repositioning Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Drug Repositioning Revenue Market Share by Application (2016-2021)
Table 29. Global Drug Repositioning Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Drug Repositioning Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Drug Repositioning Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Drug Repositioning Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Drug Repositioning Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Drug Repositioning Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Drug Repositioning Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Drug Repositioning Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Drug Repositioning Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Drug Repositioning Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Drug Repositioning Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Drug Repositioning Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Drug Repositioning Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drug Repositioning Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drug Repositioning Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drug Repositioning Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Drug Repositioning Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Drug Repositioning Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Drug Repositioning Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Drug Repositioning Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Drug Repositioning Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Drug Repositioning Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Drug Repositioning Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Drug Repositioning Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drug Repositioning Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drug Repositioning Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drug Repositioning Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Drug Repositioning Market Size by Country (2022-2027) & (US$ Million)
Table 61. Teva Company Details
Table 62. Teva Business Overview
Table 63. Teva Drug Repositioning Product
Table 64. Teva Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 65. Teva Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Drug Repositioning Product
Table 69. Novartis Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Drug Repositioning Product
Table 74. Mylan Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Drug Repositioning Product
Table 79. Johnson & Johnson Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Drug Repositioning Product
Table 84. Pfizer Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Bausch Health Company Details
Table 87. Bausch Health Business Overview
Table 88. Bausch Health Drug Repositioning Product
Table 89. Bausch Health Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 90. Bausch Health Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Drug Repositioning Product
Table 94. GSK Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 95. GSK Recent Development
Table 96. ChemRar Group Company Details
Table 97. ChemRar Group Business Overview
Table 98. ChemRar Group Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 99. ChemRar Group Recent Development
Table 100. Glenmark Company Details
Table 101. Glenmark Business Overview
Table 102. Glenmark Drug Repositioning Product
Table 103. Glenmark Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 104. Glenmark Recent Development
Table 105. Fujifilm Company Details
Table 106. Fujifilm Business Overview
Table 107. Fujifilm Drug Repositioning Product
Table 108. Fujifilm Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 109. Fujifilm Recent Development
Table 110. Dr. Reddy Company Details
Table 111. Dr. Reddy Business Overview
Table 112. Dr. Reddy Drug Repositioning Product
Table 113. Dr. Reddy Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 114. Dr. Reddy Recent Development
Table 115. R-Pharma Company Details
Table 116. R-Pharma Business Overview
Table 117. R-Pharma Drug Repositioning Product
Table 118. R-Pharma Revenue in Drug Repositioning Business (2016-2021) & (US$ Million)
Table 119. R-Pharma Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repositioning Market Share by Type: 2020 VS 2027
Figure 2. Generic Drugs Features
Figure 3. Clinical Trial Failed Drugs Features
Figure 4. Global Drug Repositioning Market Share by Application: 2020 VS 2027
Figure 5. Cardiovascular Diseases Case Studies
Figure 6. Mental Illness Case Studies
Figure 7. Cancer Case Studies
Figure 8. Others Case Studies
Figure 9. Drug Repositioning Report Years Considered
Figure 10. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Drug Repositioning Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Drug Repositioning Market Share by Regions: 2020 VS 2027
Figure 13. Global Drug Repositioning Market Share by Regions (2022-2027)
Figure 14. Global Drug Repositioning Market Share by Players in 2020
Figure 15. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repositioning as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2020
Figure 17. Global Drug Repositioning Revenue Market Share by Type (2016-2021)
Figure 18. Global Drug Repositioning Revenue Market Share by Type (2022-2027)
Figure 19. North America Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Drug Repositioning Market Share by Type (2016-2027)
Figure 21. North America Drug Repositioning Market Share by Application (2016-2027)
Figure 22. North America Drug Repositioning Market Share by Country (2016-2027)
Figure 23. United States Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Repositioning Market Share by Type (2016-2027)
Figure 27. Europe Drug Repositioning Market Share by Application (2016-2027)
Figure 28. Europe Drug Repositioning Market Share by Country (2016-2027)
Figure 29. Germany Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Repositioning Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Drug Repositioning Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Drug Repositioning Market Share by Region (2016-2027)
Figure 39. China Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Repositioning Market Share by Type (2016-2027)
Figure 47. Latin America Drug Repositioning Market Share by Application (2016-2027)
Figure 48. Latin America Drug Repositioning Market Share by Country (2016-2027)
Figure 49. Mexico Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Repositioning Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Drug Repositioning Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Drug Repositioning Market Share by Country (2016-2027)
Figure 55. Turkey Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Teva Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 64. GSK Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 65. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 66. Glenmark Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 67. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 68. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 69. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed